MIME-Version: 1.0
Server: WebSTAR/2.1 ID/32304
Message-ID: <b0b80f5a.3978@www.epixmed.com>
Date: Sat, 13 Dec 1997 15:43:53 GMT
Last-Modified: Tue, 18 Nov 1997 17:12:09 GMT
Content-type: text/html
Content-length: 3176

<HTML><HEAD>   <TITLE>Epix Medical Home Page</TITLE><META Name = "Description" Content ="EPIX Medical, Inc. (Nasdaq: EPIX) develops targeted contrast agents to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. MS-325, is an injectable contrast agent designed for multiple vascular imaging indications, including coronary artery disease and peripheral vascular disease. "><META Name = "keywords" Content = "MRI, MRA, angiography, coronary, heart, vascular, contrast, diagnose,agent, ultrasound, imaging, cardiology, embolism, clot, x-ray, radiology, cardiovascular, intravascular, PVD, angiogram, magnetic, resonance, vascular, image, diagnostic, artery, mammogram, brain, breast, CAD, cancer, gadolinium, infarction, plaque, pulmonary, thrombosis, thrombus, vein"></HEAD><BODY BGCOLOR="#FFF7FA"><P><CENTER><IMG SRC="graphics/epixbanr.gif" WIDTH=433 HEIGHT=124ALIGN=bottom><BR><A HREF="index.html"><IMG SRC="graphics/hometabs.gif" ALT="Home"WIDTH=67 HEIGHT=21 BORDER=0ALIGN=bottom></A><A HREF="index2.html"><IMGSRC="graphics/aboutabs.gif" ALT="About EPIX" WIDTH=99 HEIGHT=21BORDER=0 ALIGN=bottom></A><A HREF="ms325.html"><IMGSRC="graphics/m325tabs.gif" ALT="MS-325" WIDTH=76 HEIGHT=21 BORDER=0ALIGN=bottom></A><A HREF="technology.html"><IMGSRC="graphics/techtabs.gif" ALT="Technology R&amp;D" WIDTH=137HEIGHT=21 BORDER=0ALIGN=bottom></A><A HREF="http://www.prnewswire.com/prn/owa/cn_liststory?id=120427"><IMGSRC="graphics/newstabs.gif" ALT="News" WIDTH=54 HEIGHT=21 BORDER=0ALIGN=bottom></A><BR><A HREF="publications.html"><IMG SRC="graphics/paprtabs.gif"ALT="Publications" WIDTH=109 HEIGHT=21 BORDER=0ALIGN=bottom></A><A HREF="employment.html"><IMGSRC="graphics/jobstabs.gif" ALT="Employment Opportunities" WIDTH=107HEIGHT=21 BORDER=0 ALIGN=bottom></A><A HREF="investor.html"><IMGSRC="graphics/invetabs.gif" ALT="Investor Info" WIDTH=106 HEIGHT=21BORDER=0 ALIGN=bottom></A><A HREF="request.html"><IMGSRC="graphics/datatabs.gif" ALT="Request Information" WIDTH=111HEIGHT=21 BORDER=0 ALIGN=bottom></A></CENTER><H1><CENTER>&nbsp;MS-325 Noninvasive<BR>Cardiovascular Imaging</CENTER></H1><BLOCKQUOTE><P><CENTER><TABLE BORDER=0 WIDTH=433>   <TR>      <TD>         <P><CENTER><IMG SRC="images/xray.gif" WIDTH=202 HEIGHT=201         BORDER=0 ALIGN=left></CENTER>      </TD><TD WIDTH=22>         <P>      </TD><TD>         <P><CENTER><IMG SRC="images/calf_arteries+veins.gif"         WIDTH=202 HEIGHT=201 BORDER=0 ALIGN=left></CENTER>      </TD></TR>   <TR>      <TD>         <P><CENTER><B>Conventional X-Ray Angiography</B></CENTER>      </TD><TD WIDTH=22>         <P>      </TD><TD>         <P><CENTER><B>Angiography using Magnetic Resonance Imaging         with MS-325</B></CENTER>      </TD></TR></TABLE></CENTER></BLOCKQUOTE><P><CENTER><HR>&copy; 1997, EPIX Medical, Inc.<BR><P><CENTER>E-mail us at<A HREF="mailto:info@epixmed.com">info@epixmed.com</A></CENTER><br><br><CENTER><img src="award1.gif" alt="C1 HIT award" width=88 height=117 border=0></CENTER></BODY></HTML>